Penetration of amphotericin B lipid formulations into pleural effusion
- PMID: 17785511
- PMCID: PMC2151422
- DOI: 10.1128/AAC.01087-07
Penetration of amphotericin B lipid formulations into pleural effusion
Abstract
The penetration of the amphotericin B (AMB) lipid formulations (liposomal AMB, AMB colloidal dispersion, and AMB lipid complex formulations) into pleural effusions in seven critically ill patients was assessed. AMB was detected in all pleural effusion samples at concentrations ranging from 0.02 to 0.43 microg/ml. The penetration ratio was 3 to 44%.
References
-
- Bellmann, R., P. Egger, and C. J. Wiedermann. 2003. Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence. Clin. Infect. Dis. 36:1500-1501. - PubMed
-
- Egger, P., R. Bellmann, and C. J. Wiedermann. 2001. Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography. J. Chromatogr. B 760:307-313. - PubMed
-
- Espinel-Ingroff, A., K. Boyle, and D. J. Sheehan. 2001. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 150:101-115. - PubMed
-
- Failla, P. J., F. P. Cerise, G. H. Karam, and W. R. Summer. 1995. Blastomycosis: pulmonary and pleural manifestations. South. Med. J. 88:405-410. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
